HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Single dose pharmacokinetics of terbinafine in cats.

Abstract
The pharmacokinetics of terbinafine was studied in six healthy fasted cats following a single intravenous and oral administration at a dose of 10 mg/kg and 30 mg/kg, respectively, according to a two-period crossover design. Plasma terbinafine concentrations were determined using a reverse phase liquid chromatographic method. The pharmacokinetic parameters were calculated by non-compartmental analysis with WinNonlin 5.2.1 software. After intravenous administration, the terminal half-life and area under the curve from time 0 to infinity were 10.40 ± 4.56 h, 15.20 ± 3.61 h·µg/ml, respectively. After oral dosing, the mean maximum concentration was 3.22 ± 0.60 µg/ml, reached at 1.33 ± 0.41 h. The terminal half-life, area under the curve from time 0 to infinity and apparent volume of distribution were 8.01 ± 3.46 h, 13.77 ± 4.99 h·µg/ml, 25.63 ± 6.29 l/kg, respectively. The absolute bioavailability of terbinafine hydrochloride tablets after oral administration was 31.00 ± 10.85%. Although bioavailability was low, excellent penetration at the site of infection and low minimum inhibitory concentrations values provided terbinafine with good efficacy against dermatophyte infections.
AuthorsAng Wang, Huanzhong Ding, Yiming Liu, Yan Gao, Zhenling Zeng
JournalJournal of feline medicine and surgery (J Feline Med Surg) Vol. 14 Issue 8 Pg. 540-4 (Aug 2012) ISSN: 1532-2750 [Electronic] England
PMID22403416 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Antifungal Agents
  • Naphthalenes
  • Tablets
  • Terbinafine
Topics
  • Administration, Oral
  • Animals
  • Antifungal Agents (administration & dosage, pharmacokinetics)
  • Area Under Curve
  • Cats (blood)
  • Chromatography, High Pressure Liquid (veterinary)
  • Cross-Over Studies
  • Drug Administration Schedule (veterinary)
  • Half-Life
  • Naphthalenes (administration & dosage, pharmacokinetics)
  • Tablets
  • Terbinafine

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: